A Novel Variable Number of Tandem Repeat of the Natriuretic Peptide Precursor B gene's 5'-Flanking Region is Associated with Essential Hypertension among Japanese Females

Background: Brain natriuretic peptide (BNP) acts primarily as a cardiac hormone; it is produced by the ventricle and has both vasodilatory and natriuretic actions. Therefore, the BNP gene is thought to be a candidate gene for essential hypertension (EH). The present study identified variants in the 5'-flanking region of natriuretic peptide precursor B (NPPB) gene and assessed the relationship between gene variants and EH. Methods: The polymerase chain reaction-single strand conformation polymorphism method and nucleotide sequencing were used to identify variants. Results: A novel variable number of tandem repeat (VNTR) polymorphism in the 5'-flanking region (-1241 nucleotides from the major transcriptional initiation site) was discovered. This VNTR polymorphism is a tandem repeat of the 4-nucleotide sequence TTTC. There were 8 alleles, ranging from 9-repeat to 19-repeat. An association study was done involving 317 EH patients and 262 age-matched normotensive (NT) subjects. The 11-repeat allele was the most frequent (88.2%); the 16-repeat allele was the second most frequent (10.5%) in the NT group. The observed and expected genotypes were in agreement with the predicted Hardy-Weinberg equilibrium values (P=0.972). Among females, the overall distribution of genotypes was significantly different between the EH and NT groups (p=0.039). The frequency of the 16-repeat allele was significantly lower in the female EH group (6.5%) than in the female NT group (12.2%, p=0.046). Conclusions: The 16-repeat allele of the VNTR in the 5'-flanking region of NPPB appears to be a useful genetic marker of EH in females.

[1]  T. Nakayama,et al.  Association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects. , 2007, American journal of hypertension.

[2]  T. Nakayama,et al.  Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. , 2006, American journal of hypertension.

[3]  T. Nakayama,et al.  Association study of calcitonin-receptor-like receptor gene in essential hypertension. , 2005, American journal of hypertension.

[4]  H. Ueshima,et al.  What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? , 2005, Journal of Human Hypertension.

[5]  T. Nakayama,et al.  An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene. , 2004, American journal of hypertension.

[6]  T. Nakayama,et al.  Variable number of tandem repeat of the 5'-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[7]  K. Kario,et al.  Greater change of orthostatic blood pressure is related to silent cerebral infarct and cardiac overload in hypertensive subjects. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[8]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[9]  D. Levy,et al.  Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart Study , 2003, Hypertension.

[10]  Douglas W Mahoney,et al.  Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.

[11]  T. Nakayama,et al.  A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[12]  T. Nakayama,et al.  Structure and polymorphisms of the human natriuretic peptide receptor C gene , 2002, Endocrine.

[13]  A. Clerico,et al.  Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. , 2001, Clinical science.

[14]  T. Nakayama,et al.  Isolation of the 5'-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. , 2001, Medical science monitor : international medical journal of experimental and clinical research.

[15]  T. Nakayama,et al.  Association of 5' upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. , 2000, American journal of hypertension.

[16]  T. Nakayama,et al.  Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. , 2000, Circulation research.

[17]  Kenji Nakamura,et al.  Cardiac fibrosis in mice lacking brain natriuretic peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Nakayama,et al.  Nucleotide sequence of the 5'-flanking region of the type A human natriuretic peptide receptor gene and association analysis using a novel microsatellite in essential hypertension. , 1999, American journal of hypertension.

[19]  T. Nakayama,et al.  Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. , 1999, Circulation research.

[20]  Yusuke Nakamura,et al.  VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators , 1998, Journal of Human Genetics.

[21]  T. Nakayama,et al.  Organization of the human natriuretic peptide receptor A gene. , 1998, Biochemical and biophysical research communications.

[22]  G. Goodwin,et al.  Polymorphism in serotonin transporter gene associated with susceptibility to major depression , 1996, The Lancet.

[23]  N. Tamura,et al.  Characterization of the 5′-flanking region and chromosomal assignment of the human brain natriuretic peptide gene , 1995, Journal of Molecular Medicine.

[24]  N. Tamura,et al.  Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. , 1994, The Journal of clinical investigation.

[25]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.

[26]  K. Nakao,et al.  Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". , 1992, The Journal of clinical investigation.

[27]  K. Nakao,et al.  Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. , 1992, Journal of hypertension.

[28]  N. Minamino,et al.  C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. , 1990, Biochemical and biophysical research communications.

[29]  K. Nakao,et al.  Human brain natriuretic peptide, a novel cardiac hormone , 1990, The Lancet.

[30]  Naoto Minamino,et al.  A new natriuretic peptide in porcine brain , 1988, Nature.

[31]  K. Kangawa,et al.  Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP) , 1984 .

[32]  K. Nakao,et al.  Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. , 1992, Journal of hypertension.

[33]  K. Kangawa,et al.  Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). , 1984, Biochemical and biophysical research communications.